Clinical trials
Injection clinical trials
Below are recruiting injection clinical trials, each written for real people, not researchers. We’re tracking 2,037 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07808177RecruitingEarly Phase 1
Study of a targeted radiation drug for advanced solid tumors
This trial is testing an investigational drug called 177Lu-FAP-VG1 for people with advanced solid tumors that have stopped responding to standard therapy. The drug is a type of radiation therapy that targets a protein called FAP, which is found on many cancer cells, to try to shrink the tumor and slow the cancer's growth.
Jinan, ShandongAges 18 years+ - NCT07799688RecruitingPhase 2
Study of a new drug for high triglycerides
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
Jinan, ShandongAges 18–79 - NCT07798609RecruitingPhase 1/Phase 2
Testing SFL-0821 for people with FSHD
This study is testing a new medicine, SFL-0821, to see if it is safe and useful for people with FSHD. It may help if it works, but it is still experimental.
Concord, New South WalesAges 18–65 - NCT06518928Recruiting
AI sperm selection for IVF with ICSI
This trial tests an artificial intelligence system that helps select the best sperm for use during IVF with ICSI. The goal is to see if this improves fertilization, embryo development, and reduces early pregnancy loss.
Las Vegas, NevadaAges Any age - NCT07799155Recruiting
Epidural steroid injection for leg pain from nerve compression
This study tests a common pain-relieving injection for people with nerve pain in the lower back and leg caused by a pinched nerve. It aims to see how well the injection reduces pain and improves quality of life.
Istanbul, IstanbulAges 18–65 - NCT07797647Enrolling by invitation
Platelet-rich bladder injections for overactive bladder
This study is testing if an injection of your own platelet-rich plasma into the bladder can help with overactive bladder. The goal is to find a new treatment option for people who have not found relief from other treatments.
Chongqing, Chongqing MunicipalityAges 18–65 - NCT07797816RecruitingPhase 2
Targeted drug combo with radiation for advanced bile duct cancer
This trial tests a combination of two chemotherapy drugs and an immunotherapy drug, followed by targeted radiation, in people with bile duct or gallbladder cancer that cannot be removed with surgery. The goal is to see if this approach can shrink tumors and improve outcomes.
Nanjing, JiangsuAges 18–80 - NCT06531278RecruitingPhase 2
Adebelimab plus chemo for first-line pancreatic cancer with liver spread
This trial tests a combination of immunotherapy (adebelimab) and chemotherapy drugs (irinotecan liposome, oxaliplatin, fluorouracil, and calcium folinate) as a first treatment for pancreatic cancer that has spread to the liver. The goal is to see if this combination is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06536582Recruiting
Nutrition’s role in PRGF treatment for shoulder tendon pain
This trial studies how diet affects the success of a special blood-based treatment (PRGF) for shoulder tendon pain. It may help you heal better from tendinopathy.
MilanAges 18–70 - NCT07787741Recruiting
Cervical Epidural Injection for Chronic Neck Pain
This study tests a cervical epidural block (an injection into the neck area) as a treatment for chronic neck pain. It aims to see if this injection can help reduce pain in people with nerve-related neck pain.
Adapazarı, SakaryaAges 18–55 - NCT06537843RecruitingPhase 2
Venetoclax, cytarabine and metformin for AML
This trial tests a combination of three drugs – venetoclax, cytarabine, and metformin – for adults with AML who cannot receive standard high-dose chemotherapy. It aims to see if this gentler mix can help control the leukemia with fewer side effects.
BelémAges 18 years+ - NCT07785934RecruitingPhase 1
Testing a new weight management injection for drug interactions
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
Hefei, AnhuiAges 18–45 - NCT06394492RecruitingPhase 3
Testing a new drug for platinum-resistant ovarian cancer
This study tests a new drug called SHR-A1921 for people with ovarian cancer that no longer responds to platinum chemotherapy. The goal is to see if it can shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06550713RecruitingPhase 1
Testing TQB3455 tablets for blood cancers with IDH2 mutation
This trial tests a new tablet, TQB3455, for people with certain blood cancers (MDS or AML) that have an IDH2 mutation. The goal is to see if the drug can help when other treatments haven't worked or aren't possible.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07778069Enrolling by invitation
Virtual reality for children having joint steroid injections
This study tests whether using virtual reality (VR) during a steroid joint injection helps children feel less pain and anxiety. If it works, it could make the procedure easier for patients from 5 to 17 years old.
Columbus, OhioAges 5–17 - NCT07777926RecruitingPhase 4
Chin filler injection for chin profile enhancement
This study tests a chin filler injection to improve the shape and profile of the chin. It may help you if you are interested in a more defined chin without surgery.
Philadelphia, PennsylvaniaAges 22–55 - NCT07779343Recruiting
Multidisciplinary support for adults living with obesity
This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.
AlgiersAges 18–65 - NCT07776873RecruitingPhase 3
Clot-busting medicine for stroke symptoms 4.5 to 24 hours
This study tests a clot-busting medicine given through an IV to people who had a stroke caused by a blocked medium-sized blood vessel in the brain, and who can be treated 4.5 to 24 hours after symptoms start. The goal is to see if it improves recovery and reduces disability compared to standard care.
Hefei, AnhuiAges 18 years+ - NCT06187441RecruitingPhase 3
Testing a treatment break in multiple myeloma
This trial is for people with multiple myeloma who have already completed 12 cycles of a standard treatment (daratumumab, lenalidomide, and dexamethasone) and are doing well. It tests whether taking a break from treatment is safe and effective, instead of continuing without a break.
's-HertogenboschAges 18 years+ - NCT06560827RecruitingPhase 1
CAR-T Cells for Liver Cancer After Surgery
This trial is testing a new treatment made from your own immune cells (called CT011 CAR-T cells) to see if it can lower the risk of liver cancer coming back after surgery. It is designed for people with advanced liver cancer that has spread into nearby blood vessels.
BeijingAges 18–75 - NCT07768813RecruitingPhase 1
Comparing two versions of an injected drug in healthy and overweight people
This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.
MannheimAges 18–55 - NCT07769489RecruitingPhase 1
Comfort study of larger under-the-skin injections
This study checks if giving larger volumes of liquid under the skin (subcutaneous injection) at different speeds is comfortable and acceptable to healthy people. It aims to see how the body reacts to help make future injections more comfortable for patients.
Gentofte MunicipalityAges 18–64 - NCT02131753RecruitingPhase 2/Phase 3
Optimizing treatment for hairy cell leukemia in adults
This trial studies the best way to treat hairy cell leukemia and checks how well the approach works in people who need treatment for their disease. It may help if you have classic hairy cell leukemia and have not had certain prior chemotherapy.
AnsbachAges 18–90 - NCT07775508RecruitingPhase 1
Car t cell therapy for relapsed or refractory b cell lymphoma
This trial tests a new treatment using your own immune cells, called CAR T cells, that are specially made to find and attack cancer cells in B-cell lymphoma. It may help if your lymphoma has come back or has not gone away after other treatments.
BeijingAges 18–75
Hear when a new Injection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for injection?
- Yes. Clin2 currently lists 2,037 recruiting injection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a injection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a injection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.